RecruitingNot ApplicableNCT06469788

Testimonials and Navigation in Rheumatology

Improving COVID-19 Vaccine Uptake Among Racial and Ethnic Minority Groups With Rheumatic Diseases


Sponsor

University of Alabama at Birmingham

Enrollment

1,170 participants

Start Date

Dec 18, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The overall goal of this study is to determine whether a novel, multi-modal, patient-directed behavioral intervention initiated in rheumatology clinics is an effective approach to improve uptake of updated COVID-19 vaccine.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Adults (18+ years) with known AIRD
  • Black race and/or Latinx ethnicity
  • Individuals who have not obtained the updated COVID-19 vaccine series (self-report)

Exclusion Criteria1

  • Lack of access to phone

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALVideo comprised of AIRD patient narratives on COVID-19 vaccination thoughts and experiences

Participants will watch video focused on the importance of receipt of updated COVID-19 vaccination in patients with AIRD

BEHAVIORALVideo on the importance of good oral health for patients with AIRD

Participants will watch video on the importance of good oral health in AIRD patients.

BEHAVIORALBrochure on COVID-19 vaccination in AIRD patients

Participants

BEHAVIORALPatient Navigation

Participants will receive phone calls from patient navigators to provide support and information for receipt of updated COVID-19 vaccination in patients with AIRD

BEHAVIORALBrochure on the importance of good oral health in AIRD patients

Participants will receive a brochure on the importance of good oral health in AIRD patients.


Locations(3)

University of Alabama at Birmingham

Birmingham, Alabama, United States

Brigham Women's Hospital

Boston, Massachusetts, United States

University of Massachusetts Chan Medical School

Worcester, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06469788


Related Trials